Kuniaki Shirao

Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin

Yasuhiro Matsumura, Tsuyoshi Hamaguchi, Takashi Ura et al. · British Journal of Cancer · 2004 · 617 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study

Narikazu Boku, Seiichiro Yamamoto, Haruhiko Fukuda et al. · The Lancet Oncology · 2009 · 592 citations

Medicine, Oncology, Pharmacology +13

Randomized Phase III Trial of Fluorouracil Alone Versus Fluorouracil Plus Cisplatin Versus Uracil and Tegafur Plus Mitomycin in Patients With Unresectable, Advanced Gastric Cancer: The Japan Clinical Oncology Group Study (JCOG9205)

Atsushi Ohtsu, Yasuhiro Shimada, Kuniaki Shirao et al. · Journal of Clinical Oncology · 2002 · 431 citations

Medicine, Oncology, Pharmacology +13

Risk factors for lymph node metastasis from intramucosal gastric carcinoma

Takekazu Yamao, Kuniaki Shirao, Hiroyuki Ono et al. · Cancer · 1996 · 305 citations · Full text

Medicine, Oncology, Surgery +16

Irinotecan pharmacokinetics/pharmacodynamics and UGT1A genetic polymorphisms in Japanese: roles of UGT1A1*6 and *28

Hironobu Minami, Kimie Sai, Mayumi Saeki et al. · Pharmacogenetics and Genomics · 2007 · 288 citations

Medicine, Pharmacokinetics, Pharmacology +17